Skip to main content
. 2023 Mar 30;3:46. doi: 10.1038/s43856-023-00273-1

Table 1.

Selected patient characteristics for discovery cohort.

No future event of recurrence (n = 72) Future event of recurrence (n = 28)
Hormone Receptor positive 28 (53%) 17 (61%)
HER2 + positive 23 (32%) 11 (39%)
pCR 23 (32%) 4 (14%)
Age (min-max) 48.15 (33.18–64.33) 46.31 (28.76–65.39)